Isomura Shuichi, Onitsuka Toshiaki, Tsuchimoto Rikako, Nakamura Itta, Hirano Shogo, Oda Yuko, Oribe Naoya, Hirano Yoji, Ueno Takefumi, Kanba Shigenobu
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Affect Disord. 2016 Jan 15;190:800-806. doi: 10.1016/j.jad.2015.11.034. Epub 2015 Nov 26.
The auditory steady-state response (ASSR) elicited by gamma band neural oscillations has received considerable interest as a biomarker of psychiatric disorders. Although recent ASSR studies have reported that patients with bipolar disorder (BD) show altered ASSRs, little is known about ASSRs in patients with major depressive disorder (MDD). The aim of this study was to evaluate whether ASSRs in MDD subjects differed from those in BD subjects or normal controls (NC).
We analyzed ASSRs in 14 MDD patients, 19 BD patients, and 29 normal control subjects. We used whole-head 306-channel magnetoencephalography to evaluate ASSR power and phase-locking factors (PLF) elicited by 20-, 30-, 40-, and 80-Hz click trains. We determined optimal sensitivity and specificity of ASSR power and PLF for the diagnosis of MDD or BD via receiver operating characteristic (ROC) curve analysis using a nonparametric approach.
MDD patients exhibited no significant differences in ASSR power or PLF compared with NC subjects, while BD patients showed deficits on the ASSR measures. MDD patients showed significantly larger ASSR power and PLF for 30-, 40-, and 80-Hz stimuli compared with BD patients. The area under the curve (AUC) for the ROC analysis (MDD vs. BD) was 0.81 [95% CI=0.66-0.96, p=0.003] concerning 40-Hz ASSR power.
We could not exclude the effect of medication and the sample size of the current study is relatively small.
We could differentiate between MDD and BD subjects in terms of gamma band ASSR. Our data suggest that the 40-Hz ASSR may be a potential biomarker for differentiation between MDD and BD patients.
由伽马波段神经振荡引发的听觉稳态反应(ASSR)作为精神疾病的生物标志物受到了广泛关注。尽管最近的ASSR研究报告称双相情感障碍(BD)患者的ASSR发生了改变,但对于重度抑郁症(MDD)患者的ASSR却知之甚少。本研究的目的是评估MDD患者的ASSR是否与BD患者或正常对照(NC)不同。
我们分析了14例MDD患者、19例BD患者和29例正常对照受试者的ASSR。我们使用全头306通道脑磁图来评估由20Hz、30Hz、40Hz和80Hz的点击序列引发的ASSR功率和锁相因子(PLF)。我们通过使用非参数方法的受试者操作特征(ROC)曲线分析来确定ASSR功率和PLF对MDD或BD诊断的最佳敏感性和特异性。
与NC受试者相比,MDD患者在ASSR功率或PLF方面没有显著差异,而BD患者在ASSR测量方面表现出缺陷。与BD患者相比,MDD患者在30Hz、40Hz和80Hz刺激下表现出显著更大的ASSR功率和PLF。关于40Hz ASSR功率,ROC分析(MDD与BD)的曲线下面积(AUC)为0.81 [95% CI = 0.66 - 0.96,p = 0.003]。
我们无法排除药物的影响,并且本研究的样本量相对较小。
我们可以根据伽马波段ASSR区分MDD和BD受试者。我们的数据表明,40Hz ASSR可能是区分MDD和BD患者的潜在生物标志物。